During the last session, Anixa Biosciences Inc (NASDAQ:ANIX)’s traded shares were 0.19 million, with the beta value of the company hitting 0.33. At the end of the trading day, the stock’s price was $3.55, reflecting an intraday loss of -3.53% or -$0.13. The 52-week high for the ANIX share is $4.20, that puts it down -18.31 from that peak though still a striking 41.69% gain since the share price plummeted to a 52-week low of $2.07. The company’s market capitalization is $114.35M, and the average intraday trading volume over the past 10 days was 0.38 million shares, and the average trade volume was 104.41K shares over the past three months.
Anixa Biosciences Inc (ANIX) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 1.00. ANIX has a Sell rating from 0 analyst(s) out of 2 analysts who have looked at this stock. 0 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 2 recommend a Buy rating for it.
Anixa Biosciences Inc (NASDAQ:ANIX) trade information
Anixa Biosciences Inc (ANIX) registered a -3.53% downside in the last session and has traded in the green over the past 5 sessions. The stock plummet -3.53% in intraday trading to $3.55, hitting a weekly high. The stock’s 5-day price performance is 3.95%, and it has moved by 31.48% in 30 days. Based on these gigs, the overall price performance for the year is 36.02%. The short interest in Anixa Biosciences Inc (NASDAQ:ANIX) is 0.34 million shares and it means that shorts have 8.05 day(s) to cover.
The consensus price target of analysts on Wall Street is $10, which implies an increase of 64.5% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $10 and $10 respectively. As a result, ANIX is trading at a discount of -181.69% off the target high and -181.69% off the low.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 7.73%. While earnings are projected to return 2.80% in 2025, the next five years will return 4.43% per annum.
ANIX Dividends
Anixa Biosciences Inc is due to release its next quarterly earnings on 2025-May-28. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
Anixa Biosciences Inc (NASDAQ:ANIX)’s Major holders
Anixa Biosciences Inc insiders own 5.32% of total outstanding shares while institutional holders control 17.60%, with the float percentage being 18.59%. VANGUARD GROUP INC is the largest shareholder of the company, while 73.0 institutions own stock in it. As of 2024-06-30, the company held over 1.39 million shares (or 4.3455% of all shares), a total value of $3.08 million in shares.
The next largest institutional holding, with 0.74 million shares, is of D.A. DAVIDSON & CO.’s that is approximately 2.2974% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $1.63 million.
